Cytosorbents Corporation (CTSO)
NASDAQ · Healthcare
Cytosorbents Corporation Total Liabilities 2011–2025
Cytosorbents Corporation annual total liabilities history from 2011 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Cytosorbents Corporation total liabilities as of December 31, 2025: 38.3M, a 5.55% increase year-over-year.
- Cytosorbents Corporation total liabilities for 2025 were 38.3M, a 5.55% increase from 2024.
- Cytosorbents Corporation total liabilities for 2024 were 36.3M, a 23.04% increase from 2023.
- Cytosorbents Corporation total liabilities for 2023 were 29.5M, a 5.81% increase from 2022.
- Cytosorbents Corporation total liabilities for 2022 were 27.9M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Cytosorbents Corporation Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $38 |
| 2024 | $36 |
| 2023 | $29 |
| 2022 | $28 |
| 2021 | $27 |
| 2020 | $11 |
| 2019 | $24 |
| 2018 | $17 |
| 2017 | $14 |
| 2016 | $8 |
| 2015 | $3 |
| 2014 | $2 |
| 2013 | $3 |
| 2012 | $2 |
| 2011 | $2 |
Cytosorbents Corporation Total Liabilities — FAQ
Cytosorbents Corporation (CTSO) total liabilities over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CTSO's total liabilities history?
The chart and table above show Cytosorbents Corporation's total liabilities by year and by quarter, including the growth rate.